Maia Szalavitz is a reporter and author who focuses on science, public policy, and addiction treatment. She's the author of the New York Times bestseller Unbroken Brain: A Revolutionary New Way of Understanding Addiction.
The U.S. is conducting clinical trials of deep brain stimulation for opioid addiction, but ethical questions abound.
Quarantined people have to go out to get their prescriptions and can't get a backup supply.
Hydromorphone, aka "Dilly," is now available to people who aren't ready or able to quit opioids.
If New York's Governor Cuomo doesn’t sign these laws, he is literally condemning hundreds of people to die for the sake of insurance-company greed.
Insurers and state governments haven’t gotten up to speed with federal recommendations, and pain patients are paying the price.
Grassroots addiction groups could get tens of millions of dollars and start a long-overdue revolution in the way we care for and treat drug problems in the U.S.
OK, maybe it's not "your father's weed."
We know that politically, when turning points in crises are identified, both attention and money are drawn away from the issue.
Facebook appears to be blocking people who warn users about poisonous batches of drugs or who supply materials used to test for fentanyl.
Experts are concerned we'll see a rise in brain damage among people who survive multiple ODs in the age of fentanyl.